Stock listing
NASDAQ:SRTS Sensus Healthcare, Inc. Stock
Home listing (NASDAQ) of Sensus Healthcare, Inc.
Follow Sensus Healthcare, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SRTS
$2.26 USD -0.04 (-1.7%)
Close on Nov 20, 2026
- Day range
- $2.22 – $2.41 USDNov 20, 2026
- Volume
- 122,016 sharesNov 20, 2026
- Market cap
- $37.20M USDAt the close on Nov 20, 2026 · price × 16.46M shares outstanding
- 52-week range
- $2.14 – $5.49 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $655,511 USDMedian day 26,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SRTS · Home | $2.26 USD | -0.04 (-1.7%) | 122,016 | $2.39 | $2.41 | $2.215 | $2.30 | Close on Nov 20, 2026 |
| Frankfurt:5TX | €2.08 EUR | 0.00 (0.0%) | — | €2.08 | €2.08 | €2.08 | €2.08 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SRTS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.26 | -0.04 | -1.7% | $2.39 | $2.41 | $2.215 | 122,016 | |
| $2.30 | +0.04 | +1.8% | $2.33 | $2.405 | $2.205 | 77,187 | |
| $2.26 | -0.08 | -3.4% | $2.30 | $2.35 | $2.14 | 218,280 | |
| $2.34 | +0.015 | +0.6% | $2.30 | $2.46 | $2.30 | 147,240 | |
| $2.325 | -0.895 | -27.8% | $3.16 | $3.28 | $2.311 | 194,500 | |
| $3.22 | -0.19 | -5.6% | $3.235 | $3.44 | $3.17 | 82,700 | |
| $3.41 | +0.11 | +3.3% | $3.35 | $3.53 | $3.23 | 69,200 | |
| $3.30 | +0.12 | +3.8% | $3.16 | $3.45 | $3.143 | 153,500 | |
| $3.18 | +0.32 | +11.2% | $2.96 | $3.32 | $2.87 | 120,800 | |
| $2.86 | -0.06 | -2.1% | $2.90 | $3.00 | $2.71 | 102,700 | |
| $2.92 | -0.33 | -10.2% | $3.25 | $3.558 | $2.80 | 141,900 | |
| $3.25 | -0.035 | -1.1% | $3.20 | $3.73 | $3.07 | 473,600 | |
| $3.285 | +0.535 | +19.5% | $2.76 | $5.25 | $2.76 | 9,740,100 | |
| $2.75 | -0.01 | -0.4% | $2.76 | $2.825 | $2.75 | 13,200 | |
| $2.76 | -0.01 | -0.4% | $2.75 | $2.90 | $2.75 | 27,800 | |
| $2.77 | -0.05 | -1.8% | $2.79 | $2.83 | $2.75 | 17,600 | |
| $2.82 | +0.03 | +1.1% | $2.74 | $2.90 | $2.74 | 98,500 | |
| $2.79 | -0.03 | -1.1% | $2.81 | $2.87 | $2.68 | 60,300 | |
| $2.82 | -0.13 | -4.4% | $2.90 | $2.90 | $2.81 | 19,400 | |
| $2.95 | +0.08 | +2.8% | $2.90 | $3.04 | $2.90 | 12,500 | |
| $2.87 | +0.01 | +0.3% | $2.929 | $2.95 | $2.84 | 10,400 | |
| $2.86 | +0.11 | +4.0% | $2.76 | $2.94 | $2.76 | 5,600 | |
| $2.75 | -0.01 | -0.4% | $2.78 | $2.89 | $2.73 | 50,900 | |
| $2.76 | -0.01 | -0.4% | $2.76 | $2.864 | $2.721 | 24,700 | |
| $2.77 | 0.00 | 0.0% | $2.73 | $2.835 | $2.73 | 12,800 | |
| $2.77 | -0.09 | -3.1% | $2.85 | $2.87 | $2.71 | 26,000 | |
| $2.86 | -0.03 | -1.0% | $2.89 | $2.985 | $2.80 | 10,400 | |
| $2.89 | -0.04 | -1.4% | $2.91 | $3.00 | $2.89 | 18,400 | |
| $2.93 | -0.02 | -0.7% | $2.93 | $3.005 | $2.93 | 7,600 | |
| $2.95 | -0.02 | -0.7% | $2.97 | $3.04 | $2.93 | 13,200 | |
| $2.97 | +0.03 | +1.0% | $2.92 | $3.04 | $2.92 | 19,100 | |
| $2.94 | -0.03 | -1.0% | $2.92 | $3.05 | $2.92 | 5,900 | |
| $2.97 | +0.05 | +1.7% | $2.93 | $3.015 | $2.90 | 35,300 | |
| $2.92 | -0.06 | -2.0% | $3.04 | $3.04 | $2.92 | 16,400 | |
| $2.98 | +0.03 | +1.0% | $2.97 | $3.08 | $2.92 | 17,200 | |
| $2.95 | -0.04 | -1.3% | $3.00 | $3.05 | $2.95 | 7,600 | |
| $2.99 | -0.08 | -2.6% | $3.09 | $3.09 | $2.95 | 19,400 | |
| $3.07 | +0.075 | +2.5% | $2.975 | $3.08 | $2.97 | 39,700 | |
| $2.995 | +0.055 | +1.9% | $2.93 | $3.02 | $2.93 | 39,900 | |
| $2.94 | +0.03 | +1.0% | $2.92 | $2.98 | $2.91 | 23,900 | |
| $2.91 | -0.12 | -4.0% | $3.01 | $3.085 | $2.91 | 60,500 | |
| $3.03 | -0.07 | -2.3% | $3.09 | $3.125 | $3.02 | 45,700 | |
| $3.10 | +0.03 | +1.0% | $3.07 | $3.11 | $3.06 | 7,800 | |
| $3.07 | +0.02 | +0.7% | $3.04 | $3.095 | $3.03 | 10,000 | |
| $3.05 | -0.07 | -2.2% | $3.13 | $3.14 | $3.02 | 51,100 | |
| $3.12 | +0.05 | +1.6% | $3.10 | $3.175 | $3.09 | 6,900 | |
| $3.07 | -0.01 | -0.3% | $3.14 | $3.14 | $3.04 | 15,900 | |
| $3.08 | -0.05 | -1.6% | $3.10 | $3.165 | $3.01 | 21,500 | |
| $3.13 | -0.02 | -0.6% | $3.07 | $3.17 | $3.07 | 18,400 | |
| $3.15 | +0.03 | +1.0% | $3.13 | $3.175 | $3.10 | 8,200 | |
| $3.12 | 0.00 | 0.0% | $3.12 | $3.15 | $3.06 | 27,200 | |
| $3.12 | -0.04 | -1.3% | $3.16 | $3.16 | $3.12 | 13,600 | |
| $3.16 | -0.03 | -0.9% | $3.25 | $3.364 | $3.15 | 24,000 | |
| $3.19 | -0.07 | -2.1% | $3.17 | $3.385 | $3.11 | 16,500 | |
| $3.26 | +0.01 | +0.3% | $3.25 | $3.464 | $3.141 | 25,400 | |
| $3.25 | -0.08 | -2.4% | $3.31 | $3.38 | $3.215 | 22,100 | |
| $3.33 | -0.21 | -5.9% | $3.47 | $3.65 | $3.33 | 88,400 | |
| $3.54 | +0.02 | +0.6% | $3.56 | $3.72 | $3.49 | 139,900 | |
| $3.52 | +0.15 | +4.5% | $3.36 | $3.58 | $3.238 | 99,300 | |
| $3.37 | +0.08 | +2.4% | $3.21 | $3.44 | $3.155 | 32,600 | |
| $3.29 | -0.07 | -2.1% | $3.32 | $3.384 | $3.09 | 29,600 | |
| $3.36 | -0.13 | -3.7% | $3.50 | $3.50 | $3.36 | 44,600 | |
| $3.49 | +0.15 | +4.5% | $3.30 | $3.49 | $3.20 | 82,100 | |
| $3.34 | +0.11 | +3.4% | $3.29 | $3.343 | $3.13 | 24,600 | |
| $3.23 | +0.22 | +7.3% | $2.98 | $3.25 | $2.86 | 103,000 |
- Ticker
- NASDAQ:SRTS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
Latest earnings call · Nov 12, 2026
Sensus Healthcare (NASDAQ:SRTS) Q3 2026 Earnings Call
Replay and transcript
Latest deck · May 7, 2026
Q1 2026 Earnings Presentation
Earnings · 23 slides
Latest news
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
Nov 12, 2026
Closed $2.33 (-27.8%) on Nov 13, 2026
Sensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial Milestone
Nov 10, 2026
Closed $3.30 (+3.8%) on Nov 10, 2026
Sensus Healthcare to Report Third Quarter 2026 Financial Results and Hold Business Update Conference Call on November 12, 2026
Oct 29, 2026
Closed $2.76 (-0.4%) on Oct 30, 2026
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 13, 2026
Closed $2.86 (-9.5%) on Aug 14, 2026
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
Jul 30, 2026
Closed $2.91 (+0.7%) on Jul 31, 2026
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
May 8, 2026
Closed $3.08 (-25.1%) on May 8, 2026
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
May 7, 2026
Closed $3.08 (-25.1%) on May 8, 2026
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
Apr 23, 2026
Closed $3.94 (+0.3%) on Apr 24, 2026
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
Mar 27, 2026
Closed $3.92 (-2.2%) on Mar 27, 2026
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base
Feb 26, 2026
Closed $4.02 (+0.8%) on Feb 26, 2026
Sensus Healthcare, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 15 in the last 12 months · 130 in all · newest Nov 12, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 12, 2026
- Decks
- 3 decks · latest May 7, 2026
Where Sensus Healthcare, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SRTS · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2JPJ1 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2JPJ1 | Lang & Schwarz | Germany | EUR |
| gettex:5TX | gettex | Germany | EUR |
| BOATS:SRTS | BOATS | United States | USD |
| Frankfurt:5TX | Frankfurt | Germany | EUR |
| Dusseldorf:5TX | Dusseldorf | Germany | EUR |
| Munich:5TX | Munich | Germany | EUR |
| Stuttgart:5TX | Stuttgart | Germany | EUR |
| Tradegate:5TX | Tradegate | Germany | EUR |
Valuation
EV/sales 1.5× against a median of 1.3×: 5th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $24.56M USD
- P/E
- Loss
- EV/sales
- 1.5×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.1×
- Gross margin
- 41.8%
- Operating margin
- −74.1%
- Net margin
- −96.5%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.08
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Sensus Healthcare, Inc. · NASDAQ:SRTS | US$37.20M | US$24.56M | n/a | 1.5× | n/a | 1.1× | −96.5% | 0.0× | 1.08 |
| electroCore, Inc. · NASDAQ:ECOR | US$40.78M | US$41.51M | n/a | 1.1× | n/a | n/a | −33.5% | n/a | 1.91 |
| Elutia, Inc. · NASDAQ:ELUT | US$39.86M | US$18.87M | 0.7× | 1.5× | n/a | 2.6× | 441.2% | 0.5× | -0.06 |
| DRGEM Corp. · KRX:263690 | US$38.82M | US$32.34M | 4.3× | 0.4× | 3.2× | 0.5× | 11.2% | 0.1× | n/a |
| Cryofocus Medtech (Shanghai) Co. Ltd. Class H · HKEX:6922 | US$37.93M | US$29.04M | n/a | 2.0× | n/a | 3.8× | −40.1% | 0.0× | n/a |
| Ocumetics Technology Corp · TSXV:OTC | US$37.38M | US$37.61M | n/a | n/a | n/a | n/a | n/a | n/a | 0.14 |
| Optomed Oyj Class A · OMXHEX:OPTOMED | US$37.24M | US$32.48M | n/a | 1.8× | n/a | 1.6× | −33.9% | 0.1× | n/a |
| Epiminder Ltd. · ASX:EPI | US$36.67M | −US$13.63M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | n/a |
| Avita Corporation · TPEX:4735 | US$35.64M | US$14.80M | 5.1× | 0.5× | 4.4× | 1.0× | 23.8% | 0.0× | n/a |
| SELVAS Healthcare, Inc. · KRX:208370 | US$35.57M | US$15.08M | 5.5× | 0.6× | 8.0× | 0.6× | 27.5% | 0.0× | n/a |
| Taiwan Biomaterial Co., Ltd. · TPEX:6649 | US$35.56M | US$28.07M | 35.3× | 5.1× | 26.5× | 1.8× | 18.2% | 0.0× | n/a |
| Median of the others | US$37.31M | US$28.55M | 5.1× | 1.3× | 6.2× | 1.3× | 14.7% | 0.0× | 0.14 |
Forecasts
3 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 5.38 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.76 · 3 analysts
- Revenue, year to Dec 2026
- 18.62M · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Joseph C. Sardano | Co-Founder, Chairman & CEO |
| Javier Rampolla | Chief Financial Officer |
| Michael Sardano | President & General Counsel |
| Christopher Machuzak | Vice President of Sales |
| Jeffrey Starling | Vice President of Sales |
| Madison Foti | Vice President of Operations |
| Monica DiGioia | Vice President of Clinical Affairs |
| Raul Gonzales | Vice President of Global Quality and Regulatory |
| Stephanie Tipton | Vice President of Marketing |
| Benson Suen | Vice President of International Sales |
| Carlton Chow | Chief Technology Officer |
| Maggie Martinez | Chief Operational Officer |
Board
| Director | Role |
|---|---|
| Joseph C. Sardano | Co-Founder, Chairman & CEO |
| Anthony B. Petrelli | Director |
| Eric Sachetta | Director |
| Larry Biscotti | Director |
| Megan Cornish | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Sensus Healthcare (NASDAQ:SRTS) Q3 2026 Earnings Call | Thu, Nov 12, 2026 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q1 2026 Earnings Call | Thu, May 07, 2026 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q4 2025 Earnings Call | Thu, Feb 12, 2026 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q1 2025 Earnings Call | Thu, May 15, 2025 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q4 2024 Earnings Call | Wed, Feb 05, 2025 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q3 2024 Earnings Call | Thu, Nov 14, 2024 · 4:30 PM ET | Replay |
| Sensus Healthcare (NASDAQ:SRTS) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 · After close | −27.8% |
| Q2 2026 | Aug 13, 2026 · After close | −9.5% |
| Q1 2026 | May 7, 2026 · After close | −25.1% |
| Q4 2025 | Feb 12, 2026 · After close | −17.0% |
| Q3 2025 | Nov 6, 2025 · After close | +19.3% |
| Q2 2025 | Aug 7, 2025 · After close | −35.2% |
| Q1 2025 | May 15, 2025 · After close | −4.3% |
| Q4 2024 | Feb 5, 2025 · After close | −32.4% |
| Q3 2024 | Nov 14, 2024 · After close | +4.8% |
| Q2 2024 | Aug 8, 2024 · After close | +1.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 10, 2024 · After close | +2.1% |
| Q4 2023 | Feb 8, 2024 · After close | +6.3% |
| Q3 2023 | Nov 9, 2023 · After close | −14.4% |
| Q2 2023 | Aug 3, 2023 · After close | +14.0% |
| Q1 2023 | May 3, 2023 · After close | −44.4% |
| Q4 2022 | Feb 9, 2023 · After close | −20.4% |
| Q3 2022 | Nov 3, 2022 · After close | −51.2% |
| Q2 2022 | Aug 4, 2022 · After close | +30.7% |
| Q1 2022 | May 5, 2022 · After close | +8.9% |
| Q4 2021 | Feb 10, 2022 · After close | +3.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2026 Earnings Presentation | Earnings | 23 slides | May 7, 2026 |
| IPO Roadshow (May 2016) | IPO roadshow | 42 slides | May 19, 2016 |
| IPO Roadshow (March 2016) | IPO roadshow | 43 slides | Mar 10, 2016 |
IPO
Priced at US$5.50 a unit on Jun 2, 2016.
- Price
- US$5.50 a unit
- Units offered
- 2,000,000 units
- Offering size
- US$11 million
- Underwriters' option
- Up to 300,000 more units
- Underwriters
- Northland Capital Markets, Neidiger, Tucker, Bruner, Inc. · In the order on the cover
- Units delivered
- On or about Jun 8, 2016
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 30, 2015 |
| Filed publicly | Feb 10, 2016 |
| Amended 4 times | Newest May 19, 2016 |
| Shares registered with an exchange | Mar 10, 2016 |
| Declared effective by the SEC | Jun 2, 2016 |
| Final prospectus, with the price | Jun 3, 2016 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 3, 2016 |
| CERTNAS · Nasdaq's certificate of listing | Jun 2, 2016 |
| EFFECT · Notice that a registration is effective | Jun 2, 2016 |
| S-1MEF · Registration of more shares for the same offering | Jun 2, 2016 |
| CORRESP · Letter to the SEC | Jun 2, 2016 |
| CORRESP · Letter to the SEC | May 31, 2016 |
| CORRESP · Letter to the SEC | May 31, 2016 |
| FWP · Free writing prospectus | May 19, 2016 |
| CORRESP · Letter to the SEC | May 19, 2016 |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | May 19, 2016 |
All 27 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | May 19, 2016 |
| UPLOAD · Letter from the SEC | May 18, 2016 |
| S-1/A · Registration statement, amended | May 13, 2016 |
| CERTNAS · Nasdaq's certificate of listing | Mar 29, 2016 |
| CORRESP · Letter to the SEC | Mar 25, 2016 |
| S-1/A · Registration statement, amended | Mar 25, 2016 |
| CORRESP · Letter to the SEC | Mar 24, 2016 |
| FWP · Free writing prospectus | Mar 10, 2016 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 10, 2016 |
| S-1/A · Registration statement, amended | Mar 10, 2016 |
| CORRESP · Letter to the SEC | Mar 9, 2016 |
| UPLOAD · Letter from the SEC | Feb 23, 2016 |
| S-1 · Registration statement | Feb 10, 2016 |
| CORRESP · Letter to the SEC | Feb 9, 2016 |
| UPLOAD · Letter from the SEC | Jan 27, 2016 |
| DRSLTR · Letter to the SEC with a draft | Dec 30, 2015 |
| DRS · Draft registration statement | Dec 30, 2015 |
Open IPO · From the cover of the final prospectus (424B4) filed Jun 3, 2016
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.5M | 41.8M | 24.4M | 44.5M | 27.0M | 9.58M | 27.3M | 26.4M | 20.6M | 14.8M |
| Cost of revenue | 15.6M | 17.4M | 10.3M | 14.9M | 10.1M | 4.33M | 9.71M | 9.52M | 6.79M | 4.97M |
| Gross profit | 11.9M | 24.4M | 14.1M | 29.6M | 17.0M | 5.25M | 17.6M | 16.9M | 13.8M | 9.85M |
| Research and development | 7.78M | 4.22M | 3.68M | 3.46M | 3.44M | 4.16M | 6.42M | 6.26M | 5.49M | 1.82M |
| Selling, general and administrative | 7.87M | 7.15M | 5.16M | 5.01M | 4.59M | 3.99M | 4.00M | 4.12M | 3.72M | 3.47M |
| Operating income | -10.3M | 8.09M | -382.0K | 14.8M | 4.12M | -8.23M | -1.97M | -2.01M | -3.72M | -363.1K |
| Depreciation and amortization | 400.0K | 200.0K | 275.0K | 315.0K | 613.0K | 722.0K | 545.7K | 658.3K | 387.9K | 337.6K |
| EBITDA | -9.91M | 8.29M | -107.0K | 15.1M | 4.73M | -7.51M | -1.42M | -1.35M | -3.33M | -25.5K |
| Interest expense | -932.0K | -992.0K | -380.0K | 2.00K | 14.0K | 14.4K | 156.7K | 68.9K | 21.9K | |
| Income before tax | -9.62M | 9.02M | 652.0K | 28.0M | 4.12M | -6.84M | -1.70M | -2.02M | -3.71M | -346.4K |
| Income tax | -1.91M | 2.38M | 167.0K | 3.75M | -613.0K | -2.12M | -545.7K | 139.3K | -312.1K | -299.0K |
| Net income | -7.72M | 6.65M | 485.0K | 24.2M | 4.12M | -6.84M | -1.70M | -2.02M | -3.71M | -346.4K |
| Earnings per share, basic | -0.47 | 0.41 | 0.03 | 1.47 | 0.25 | -0.42 | -0.10 | -0.14 | -0.28 | -0.03 |
| Earnings per share, diluted | -0.47 | 0.41 | 0.03 | 1.46 | 0.25 | -0.42 | -0.10 | -0.14 | -0.28 | -0.03 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 22.1M | 22.1M | 23.1M | 25.5M | 14.5M | 14.9M | 8.10M | 12.5M | 10.1M | 5.04M |
| Short-term investments | 0 | 7.39M | 2.89M | 1.10M | 6.46M | |||||
| Receivables | 6.04M | 19.7M | 10.6M | 17.3M | 12.1M | 3.78M | 14.0M | 13.1M | 4.96M | 3.10M |
| Inventory | 14.6M | 10.1M | 11.9M | 3.50M | 1.76M | 4.43M | 3.00M | 1.63M | 1.17M | 1.25M |
| Current assets | 45.9M | 56.7M | 49.5M | 53.2M | 31.2M | 25.2M | 34.0M | 31.9M | 17.9M | 16.8M |
| Property, plant and equipment | 1.98M | 2.00M | 464.0K | 243.0K | 605.0K | 1.36M | 1.08M | 891.0K | 394.1K | 433.4K |
| Goodwill | 0 | 0 | ||||||||
| Total assets | 53.0M | 62.2M | 53.7M | 56.7M | 32.2M | 28.0M | 36.9M | 33.3M | 18.8M | 18.9M |
| Accounts payable | 3.34M | 4.81M | 2.79M | 5.52M | 4.06M | 2.87M | 4.78M | 5.17M | 4.07M | 2.76M |
| Current liabilities | 4.72M | 5.88M | 4.21M | 7.70M | 5.96M | 4.86M | 6.47M | 6.02M | 4.87M | 3.66M |
| Long-term debt | 266.8K | 2.21M | 0 | |||||||
| Total debt | 680.0K | 602.0K | 783.0K | 1.02M | 225.0K | 1.38M | 1.43M | 2.21M | ||
| Total liabilities | 4.94M | 6.34M | 4.87M | 8.67M | 6.22M | 6.51M | 8.92M | 6.79M | 7.15M | 3.67M |
| Shareholders' equity | 48.1M | 55.8M | 48.8M | 48.1M | 26.0M | 21.5M | 28.0M | 26.5M | 11.7M | 15.3M |
| Shares outstanding | 16.5M | 16.5M | 16.4M | 16.4M | 16.6M | 16.5M | 16.5M | 16.1M | 13.5M | 13.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 528.0K | -831.0K | -2.15M | -1.41M | -286.0K | -434.0K | -2.11M | -8.56M | -3.06M | -851.0K |
| Capital spending | -196.0K | -276.0K | -229.0K | -159.0K | -128.0K | -359.0K | -400.6K | -854.8K | -287.6K | -286.0K |
| Free cash flow | 332.0K | -1.11M | -2.37M | -1.57M | -414.0K | -793.0K | -2.51M | -9.42M | -3.34M | -1.14M |
| Cash from investing | -196.0K | -276.0K | -187.0K | 14.8M | 129.0K | 7.03M | -4.90M | -2.64M | 6.17M | -7.85M |
| Cash from financing | -305.0K | 15.0K | -40.0K | -2.43M | -231.0K | 211.0K | 2.62M | 13.6M | 1.93M | 8.68M |
| Dividends paid | -731.0K | -210.3K | 0 | -2.55M | ||||||
| Share buybacks | -300.0K | -52.0K | -27.0K | -3.00M | -15.0K | -57.0K | -118.8K | -118.6K | -289.3K | 13.8M |
| Change in cash | 27.0K | -1.09M | -2.37M | 11.0M | -388.0K | 6.81M | -4.38M | 2.40M | 5.04M | -22.6K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| 8-K · Current report | Jun 5, 2026 | Material contract | SEC |
| 8-K · Current report | Jun 2, 2026 | Meeting outcome | SEC |
| SD · Specialized disclosure | May 15, 2026 | ESG report | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| DEF 14A · Proxy statement | Apr 29, 2026 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Apr 23, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 22, 2026 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Apr 22, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 22, 2026 | Insider trade | SEC |
| 10-K · Annual report | Mar 4, 2026 | Annual report | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 18, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 12, 2026 | Results | SEC |
| 8-K · Current report | Jan 20, 2026 | Current report | SEC |
| 8-K · Current report | Jan 9, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Dec 16, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Nov 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 13, 2025 | Management or board change | SEC |
| 4/A · Change in ownership, amended | Nov 13, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| S-8 · Registration statement for employee plans | Aug 15, 2025 | Offer document | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2025 | Results | SEC |
| 3 · Initial statement of ownership | Jun 10, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 2, 2025 | Meeting outcome | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 22, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 15, 2025 | Results | SEC |
| DEF 14A · Proxy statement | Apr 29, 2025 | Meeting notice | SEC |
| 10-K · Annual report | Mar 5, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 11, 2025 | Current report | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 7, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Feb 5, 2025 | Results | SEC |
| 4 · Change in ownership | Dec 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 18, 2024 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 14, 2024 | Results | SEC |
| 8-K · Current report | Sep 11, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| 4 · Change in ownership | Jul 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 17, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jul 17, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jul 17, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 5, 2024 | Meeting outcome | SEC |
| 8-K · Current report | May 30, 2024 | Management or board change | SEC |
| 4 · Change in ownership | May 24, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 20, 2024 | ESG report | SEC |
| 10-Q · Quarterly report | May 10, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2024 | Results | SEC |
| DEF 14A · Proxy statement | Apr 29, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 18, 2024 | Meeting notice | SEC |
| 10-K · Annual report | Mar 15, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 8, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 6, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 2, 2024 | Management or board change | SEC |
| 8-K · Current report | Jan 18, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jan 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2023 | Results | SEC |
| 4 · Change in ownership | Sep 18, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 14, 2023 | Material contract | SEC |
| 4 · Change in ownership | Aug 28, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 11, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 11, 2023 | Current report | SEC |
| 4 · Change in ownership | Aug 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 8, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 3, 2023 | Results | SEC |
| 4 · Change in ownership | Jul 31, 2023 | Insider trade | SEC |
| 8-K · Current report | Jun 6, 2023 | Management or board change | SEC |
| 4 · Change in ownership | May 31, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | May 11, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2023 | Insider trade | SEC |
| 8-K · Current report | May 3, 2023 | Results | SEC |
| DEF 14A · Proxy statement | May 1, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 19, 2023 | Meeting notice | SEC |
| 10-K · Annual report | Mar 23, 2023 | Annual report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 9, 2023 | Results | SEC |
| 4 · Change in ownership | Feb 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 1, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 11, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 9, 2023 | Results | SEC |
| 10-Q · Quarterly report | Nov 10, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 3, 2022 | Results | SEC |
| 4 · Change in ownership | Sep 15, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Sep 7, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 12, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 4, 2022 | Results | SEC |
| 4 · Change in ownership | Jul 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jul 25, 2022 | Insider trade | SEC |
| 8-K · Current report | Jun 9, 2022 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 12, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | May 12, 2022 | Insider trade | SEC |
| 8-K · Current report | May 5, 2022 | Results | SEC |
| DEF 14A · Proxy statement | Apr 29, 2022 | Meeting notice | SEC |
| 10-K · Annual report | Mar 25, 2022 | Annual report | SEC |
| 4 · Change in ownership | Mar 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2022 | Insider trade | SEC |
| 8-K · Current report | Mar 9, 2022 | Current report | SEC |
| 4 · Change in ownership | Mar 8, 2022 | Insider trade | SEC |
| 8-K · Current report | Mar 3, 2022 | Acquisition or disposal | SEC |
| 8-K · Current report | Feb 10, 2022 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 7, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Jan 31, 2022 | Management or board change | SEC |
| 8-K · Current report | Jan 5, 2022 | Results | SEC |
| 4 · Change in ownership | Dec 17, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2021 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 16, 2021 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 16, 2021 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 16, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 13, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 13, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 10, 2021 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2021 | Results | SEC |
| SC 13G · Big-stake notice | Sep 10, 2021 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 13, 2021 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2021 | Results | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 23, 2021 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2021 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 14, 2021 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2021 | Results | SEC |
| DEF 14A · Proxy statement | Apr 30, 2021 | Meeting notice | SEC |
| 5 · Annual statement of ownership | Apr 27, 2021 | Insider trade | SEC |
| 5 · Annual statement of ownership | Apr 27, 2021 | Insider trade | SEC |
| 5 · Annual statement of ownership | Apr 27, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Apr 27, 2021 | Insider trade | SEC |
| 5 · Annual statement of ownership | Apr 27, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Apr 27, 2021 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 27, 2021 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Apr 27, 2021 | Insider trade | SEC |
| 10-K · Annual report | Mar 5, 2021 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2021 | Results | SEC |
| 3 · Initial statement of ownership | Feb 4, 2021 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 11, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 10, 2020 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2020 | Management or board change | SEC |
| 8-K · Current report | Nov 5, 2020 | Results | SEC |
| 10-K/A · Annual report, amended | Oct 1, 2020 | Annual report | SEC |
| 10-Q · Quarterly report | Aug 10, 2020 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2020 | Results | SEC |
| 8-K · Current report | Aug 4, 2020 | Current report | SEC |
| 4 · Change in ownership | Jun 10, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2020 | Insider trade | SEC |
| 8-K · Current report | Jun 5, 2020 | Meeting outcome | SEC |
| 25-NSE | Jun 4, 2020 | Other filings | SEC |
| 8-K · Current report | Jun 1, 2020 | Current report | SEC |
| SD · Specialized disclosure | May 29, 2020 | ESG report | SEC |
| 10-Q · Quarterly report | May 11, 2020 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2020 | Results | SEC |
| DEFR14A | May 5, 2020 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 29, 2020 | Meeting notice | SEC |
| 10-K · Annual report | Mar 6, 2020 | Annual report | SEC |
| 8-K · Current report | Feb 13, 2020 | Results | SEC |
This page holds 200 of 412 filings. Open Filings
Cap table
Built by 6ix from Sensus Healthcare, Inc.’s releases · as of Nov 10, 2026
- Common shares
- 16,462,059
- Fully diluted
- 16,462,059
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 16,462,059 | Nov 10, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 10, 2026 | 16,462,059 |
| Sep 30, 2026 | 16,462,059 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anthony B. Petrelli Other companies: Ring Energy, Inc. (Director · Since at least Jan 23, 2013); Charlie's Holdings, Inc. (Director · Aug 17, 2007 – Aug 19, 2008 · Past); Arena Resources Inc (Director · Jan 22, 2007 – Jul 16, 2010 · Past) | Director · Since at least Jul 21, 2016 |
| Arthur Levine Other companies: NextNRG, Inc. (Chief Financial Officer · Sep 14, 2021 – Jan 20, 2022 · Past); Trade Street Residential Inc (Chief Accounting Officer · May 13, 2013 – May 16, 2013 · Past) | CHIEF FINANCIAL OFFICER · Jun 2, 2016 – Jun 2, 2019 · Past |
| Benson Suen | Vice President of International Sales · Since at least Jul 24, 2025 |
| Carlton Chow | Chief Technology Officer · Since at least May 19, 2025 |
| Christopher Machuzak | Vice President of Sales · Since at least Nov 4, 2026 |
| Darrell S Rigel | Director · Jun 8, 2016 – Jun 8, 2016 · Past |
| Emiliano Sosa | Chief Technology Officer · Jan 3, 2023 – Jan 3, 2023 · Past |
| Eric Sachetta | Director · Since at least Nov 10, 2025 |
| Javier Rampolla | Chief Financial Officer · Since at least Jan 6, 2020 |
| Jeffrey Starling | Vice President of Sales · Since at least Nov 4, 2026 |
All 30 people
| Person | Seat |
|---|---|
| John Heinrich | Director · Jun 2, 2016 – May 17, 2024 · Past |
| Joseph C. Sardano | Co-Founder, Chairman & CEO · Since at least Jun 2, 2016 |
| Kalman Fishman | CHIEF TECHNOLOGY OFFICER · Jun 2, 2016 – Mar 22, 2019 · Past |
| Larry Biscotti | Director · Since at least Jan 7, 2026 |
| Larry Joseph Biscotti | Director · Since at least Jan 5, 2026 |
| Madison Foti | Vice President of Operations · Since at least Nov 5, 2026 |
| Magdalena Martinez | CHIEF OPERATING OFFICER · Since at least Jan 3, 2023 |
| Maggie Martinez | Chief Operational Officer · Since at least Nov 4, 2026 |
| Megan Cornish | Director · Since at least Jan 1, 2021 |
| Michael Sardano | President & General Counsel · Since at least Oct 19, 2017 |
| Monica DiGioia | Vice President of Clinical Affairs · Since at least Nov 4, 2026 |
| Nicolas Soro | CHIEF OPERATING OFFICER · Jan 6, 2019 – Mar 9, 2022 · Past |
| Raul Gonzales | Vice President of Global Quality and Regulatory · Since at least Nov 5, 2026 |
| Richard Golin | EXECUTIVE VICE PRESIDENT · Jun 2, 2016 – Mar 20, 2019 · Past |
| Russ Price | Chief Technology Officer · Jan 6, 2020 – Jan 6, 2020 · Past |
| Samuel O'Rear | Director · Jun 2, 2016 – May 8, 2023 · Past |
| Stephanie Tipton | Vice President of Marketing · Since at least Nov 4, 2026 |
| Stephen Brad Cohen | EXECUTIVE VICE PRESIDENT · Jun 2, 2016 – Dec 15, 2021 · Past |
| William H McCall | Director · Jun 2, 2016 – Dec 17, 2024 · Past |
| Yonatan Vainer | Chief Technology Officer · Jan 1, 2021 – Jan 1, 2021 · Past |
Log in to ask 6ix AI your own questions about Sensus Healthcare, Inc.